Eplerenone in the Management of Abdominal Aortic Aneurysms

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 172 participants.

Also called NCT02345590

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 172 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02345590
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Australia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02345590. Randomized; quadruple masking; primary purpose treatment. Start 2015-05 (registry gives no type); primary completion 2018-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Eplerenone in the Management of Abdominal Aortic Aneurysms
Condition
Aortic Aneurysm, Abdominal
Intervention (Drug)
Eplerenone
Lead sponsor
Bayside Health (class: other government)
Collaborator
Baker Heart and Diabetes Institute (class: other)

Record details

Record id
cardio:ct-nct02345590
Content hash
d083f9837a01f0a9a4fa8406a297dece5d31f966431125e66fa17267e501e8ed